Scholarlink

<p>This study evaluated the utility of 3,4-dihydroxy-6-[18F]-fluoro-l-phenylalanine (<sup>18</sup>F-FDOPA) positron emission tomography/computed tomography (PET/CT) for the differential diagnosis of canine pheochromocytoma. In some cases, conventional diagnostic methods, including hormonal assays and imaging modalities, may have limited ability to differentiate adrenal tumor types in dogs. <sup>18</sup>F-FDOPA PET/CT, a novel nuclear imaging modality, addresses these limitations by providing functional assessment of catecholamine-producing cells, offering higher accuracy and specificity in detecting pheochromocytomas. In this study, <sup>18</sup>F-FDOPA PET/CT was effective in localizing a pheochromocytoma, guiding surgical intervention, and aiding clinical decision-making. In cases of adrenocortical tumors clinically mimicking pheochromocytoma, <sup>18</sup>F-FDOPA PET/CT revealed no significant uptake, facilitating the identification of alternative adrenal pathologies. These results highlight the potential utility of <sup>18</sup>F-FDOPA PET/CT as a complementary diagnostic tool in cases where conventional methods yield inconclusive results. These findings suggest that using <sup>18</sup>F-FDOPA PET/CT as a standard diagnostic tool for canine adrenal tumors can enhance diagnostic accuracy and improve treatment planning. Further studies are recommended to validate these findings in larger populations and to establish standardized protocols for veterinary practice.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Utility of 18F-FDOPA PET/CT in the differential diagnosis of canine pheochromocytoma and adrenocortical tumors clinically mimicking pheochromocytoma

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年12月23日

查看全文
  • Yeon Chae,
  • Hyunglak Son,
  • Su-Hyeon Kim,
  • Hakhyun Kim,
  • Byeong-Teck Kang,
  • Sungin Lee

摘要

This study evaluated the utility of 3,4-dihydroxy-6-[18F]-fluoro-l-phenylalanine (18F-FDOPA) positron emission tomography/computed tomography (PET/CT) for the differential diagnosis of canine pheochromocytoma. In some cases, conventional diagnostic methods, including hormonal assays and imaging modalities, may have limited ability to differentiate adrenal tumor types in dogs. 18F-FDOPA PET/CT, a novel nuclear imaging modality, addresses these limitations by providing functional assessment of catecholamine-producing cells, offering higher accuracy and specificity in detecting pheochromocytomas. In this study, 18F-FDOPA PET/CT was effective in localizing a pheochromocytoma, guiding surgical intervention, and aiding clinical decision-making. In cases of adrenocortical tumors clinically mimicking pheochromocytoma, 18F-FDOPA PET/CT revealed no significant uptake, facilitating the identification of alternative adrenal pathologies. These results highlight the potential utility of 18F-FDOPA PET/CT as a complementary diagnostic tool in cases where conventional methods yield inconclusive results. These findings suggest that using 18F-FDOPA PET/CT as a standard diagnostic tool for canine adrenal tumors can enhance diagnostic accuracy and improve treatment planning. Further studies are recommended to validate these findings in larger populations and to establish standardized protocols for veterinary practice.